Publicaciones en colaboración con investigadores/as de Thrombosis Research Institute (8)

2023

  1. Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials

    Thrombosis Research, Vol. 230, pp. 27-32

  2. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 3063-3071

2022

  1. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19

    The Lancet Oncology, Vol. 23, Núm. 7, pp. e334-e347

  2. Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial

    The Lancet Haematology, Vol. 9, Núm. 8, pp. e594-e604

2020

  1. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update

    Journal of Clinical Oncology, Vol. 38, Núm. 5, pp. 496-520

2015

  1. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update 2014

    Journal of Clinical Oncology, Vol. 33, Núm. 6, pp. 654-656

2013

  1. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

    Journal of Clinical Oncology, Vol. 31, Núm. 17, pp. 2189-2204

2007

  1. Venous thromboembolism (VTE) in Europe - The number of VTE events and associated morbidity and mortality

    Thrombosis and Haemostasis, Vol. 98, Núm. 4, pp. 756-764